Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32138
Title: Assessing Low-Risk Penicillin Allergies in Critical COVID-19, A Novel Perspective on an Emerging Antibiotic Allergy Opportunity.
Austin Authors: Rose, Morgan T ;Trubiano, Jason 
Affiliation: The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Department of Infectious Diseases, University of Melbourne, Melbourne, Victoria, Australia.
Infectious Diseases
Issue Date: Feb-2023
Publication information: The journal of allergy and clinical immunology. In practice 2023; 11(2): 636-637
URI: https://ahro.austin.org.au/austinjspui/handle/1/32138
DOI: 10.1016/j.jaip.2022.11.048
ORCID: 
Journal: The journal of allergy and clinical immunology. In practice
Start page: 636
End page: 637
PubMed URL: 36759082
ISSN: 2213-2201
Type: Journal Article
Subjects: COVID-19
Penicillin allergy
Drug Hypersensitivity/diagnosis
Drug Hypersensitivity/epidemiology
Drug Hypersensitivity/drug therapy
Anti-Bacterial Agents/adverse effects
Penicillins/adverse effects
Hypersensitivity/drug therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

64
checked on May 16, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.